U.S. Markets open in 41 mins

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.5849-0.0151 (-2.52%)
At close: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.6000
Bid0.5800 x 1100
Ask0.5998 x 2900
Day's Range0.5651 - 0.6150
52 Week Range0.5400 - 3.7700
Avg. Volume2,043,411
Market Cap51.625M
Beta (5Y Monthly)1.02
PE Ratio (TTM)N/A
EPS (TTM)-0.7740
Earnings DateFeb 28, 2022 - Mar 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.83
  • TipRanks

    These 2 Penny Stocks Are Set for Massive Gains, Says Oppenheimer

    What kind of stocks stir up controversy like no other? Penny stocks. These tickers trading for less than $5 per share have earned a reputation as some of the most divisive names on Wall Street, with these plays either met with open arms or given the cold shoulder. It’s understandable why some investors are wary. Those opposed are quick to point out that there could be a very real reason these stocks are changing hands for pocket change, with the low share prices often masking obstacles like weak

  • Zacks

    Agile Therapeutics (AGRX) Reports Q3 Loss, Lags Revenue Estimates

    Agile Therapeutics (AGRX) delivered earnings and revenue surprises of 5.26% and -13.62%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Agile Therapeutics Reports Third Quarter 2021 Financial Results

    Prescription Demand Growth Continues in the Third Quarter 2021 with a 61% Increase in Twirla Cycles Dispensed Twirla Refill Rates Continue to Grow by 86% in Third Quarter 2021 Company Advances Programs Focused on Increasing Demand for Twirla Management to Host Conference Call Today, Tuesday, November 2, 2021 at 4:30 p.m. EDT PRINCETON, N.J., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three mont